Proactive Care Coordination for Cancer Survivors Who Smoke

Using Cancer Registry Data to Promote Proactive Tobacco Cessation Among Adult Cancer Survivors U48

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02723656

Enrollment

581

Registered

2016-03-30

Start date

2016-03-31

Completion date

2018-09-29

Last updated

2018-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

smoking, cancer, cancer registry, smoking cessation

Brief summary

This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will react to proactive tobacco related communications. Investigators will compare the reach and efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm 1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm randomized design at two urban cancer centers, and will explore cancer survivor attitudes and preferences about proactive tobacco treatment.

Interventions

BEHAVIORALOnline Referral NYS Quitline

Care coordinator will make an online referral to the NYS Quitline.

BEHAVIORALTobacco cessation counseling and coordination of cessation medications

Care coordinator will obtain verbal consent to transfer the patient to the NYS Quitline via 3-way call (warm transfer). The care coordinator will also assist the patient in obtaining NRT from a regular care provider, then call the patient every three months for 12 months to assess current smoking and offer to help smokers obtain additional cessation counseling and medications.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* ICD 9 cancer diagnosis seen at each site in the past two years * Documentation of current smoking in the cancer registry.

Exclusion criteria

* Dementia * Stage IV or Stage IIIB cancer

Design outcomes

Primary

Measure	Time frame
Proportion of patients in the study's original proactive outreach cohort of N=600 who complete at least one call with the Quitline	12 Months

Secondary

Measure	Time frame
biochemically validated 7-day abstinence	6 Months, 12 Months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026